About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study of LY3050258 in Healthy Participants | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT01929707

A Study of LY3050258 in Healthy Participants

The main purpose of this study is to evaluate the safety and how well the body will handle a single dose of increasing strength of study drug LY3050258. Each participant will receive LY3050258 or plac...

Lead sponsor: Eli Lilly and Company•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Eli Lilly and Company

Age

30 - 80 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Healthy males or healthy postmenopausal females, including Japanese participants
•Have a body mass index (BMI) of 18 to 35 kilograms per square meter (kg/m\^2)

Exclusion Criteria

•An abnormal sitting blood pressure as determined by the investigator
•Any abnormality in the 12-lead electrocardiogram (ECG) that, in the opinion of the investigator, places the participant at an unacceptable risk for study participation
•Current use of statins within the last 3 months prior to dosing
•Current or previous use of anabolic steroids in the preceding 6 months prior to dosing
•Use of dehydroepiandrosterone, other potential over-the-counter (OTC) steroidal supplements, or other nutritional products intended to have weight-reduction and/or performance-enhancing effects within 21 days prior to dosing

Related studies

Gait Analysis Parameter and Upper Limb Evaluation in Control Participants

NCT07136506 · Healthy Participants

RECRUITINGPhase 1

A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234

NCT07220954 · Healthy Participants

RECRUITINGPhase 1

A Trial to Assess Safety, Tolerability, and Pharmacokinetics of AN01 Inhalation Powder in Healthy Participants

NCT07554365 · Healthy Volunteer, Healthy Participants Study

RECRUITINGPhase 1

Study of BW-50218 in Healthy Participants

NCT07401472 · Healthy Participants Study

RECRUITINGPhase 1

A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity

NCT07310901 · Obese But Otherwise Healthy Participants

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 27, 2018Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment38

Start dateAug 2013

Last updatedAug 27, 2018

Condition

Healthy Participants

Locations shown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 27, 2018Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions